ONCY is trading at $0.90 (-5.03%) following a sharp intraday selloff despite a lack of company-specific news or regulatory updates.

  • No earnings releases, FDA-related events, or material corporate announcements have been identified to explain the downward move.
  • The broader market is showing mixed results, with the NASDAQ Composite down 0.56%, which may be adding mild pressure to the stock.